Company intelligence / Profile preview

Love Lifesciences

Overland Park, Kansas, United Stateslovelifesciences.com ↗

Ownership: Private
Employees: ~15
Development stage: Preclinical

Overview

Love Lifesciences is developing a series of therapeutic agnostic, hybrid injection devices—most notably the UniPen—to improve the patient experience with chronic injectable therapies. Their lead product, UniPen, is designed to enhance safety, reduce pain and anxiety associated with injections, and streamline regulatory pathways for pharmaceutical partners. The company has raised over $1.6M in pre-seed funding to advance its products through regulatory clearance and expand R&D efforts.

Therapeutic areas: OtherEndocrinology
Modalities: Device (injection device)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

UniPen

Pre-clinical

Indications: Chronic injection therapeutics

Partnerships

Digital Health KCBioNexus KCBioKansas

Beyond the preview

Go deeper on Love Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Love Lifesciences.

Explore the full profile